Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 9;6(1):e1032.
doi: 10.1002/hsr2.1032. eCollection 2023 Jan.

Androgenic-anabolic steroid abuse trend and management: A prospective, cross-sectional, questionnaire-based survey

Manaf Al Hashimi  1   2 , Yasser Farahat  3 , Hussein Kandil  4 , Ismail Al Khalidi  5
Affiliations

Androgenic-anabolic steroid abuse trend and management: A prospective, cross-sectional, questionnaire-based survey

Manaf Al Hashimi et al. Health Sci Rep. .

Abstract

Background and aims: Androgenic-anabolic steroid (AAS) abuse is a global health concern, studies revealing an increasing trend of abuse and deleterious effects on reproductive health. Unfortunately, there is no consensus about management pathways due to the lack of specific guidelines.

Methods: A prospective study, multicentre, online survey, composed of 30 questions, was conducted to investigate the current trend of AAS abuse and the management followed by practitioners from different specialities dealing with this condition.

Results: A total of 151 respondents were included. The majority were general urologists (68.21%), andrologists (22.51%), and endocrinologists (9.28%). An increasing trend of AAS abuse was noticed by 90.73% of participants mostly in young age populations. Most of AAS abusers were presented with infertility (64.24%) and erectile dysfunction (59.60%), and their investigations showed abnormal semen analysis (77.48%), abnormal hormones (follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol) (94.70%), and reduction in testicular size (50.33%). Most of respondents expected: the need of long duration for spontaneous recovery (6-12 months), relapse of AAS abuse in one-third of patients, less knowledge about the adverse effects (39.74%), and risk of drug dependence (54.30%). Immediate treatment was the most offered plan of management (44.37%) followed by a waiting spontaneous recovery (32.45%), while the remaining would refer the patients to an either endocrinologist or andrologist. The treating physicians did not follow specific guidelines and most of participants (44.44%) reverted to their personal experience in the management.

Conclusions: Our study revealed an increasing trend of AAS abuse, deleterious effects of AAS use on reproductive health, and lack of consensuses among the treating physicians regarding the management of related adverse effects. Our study could be considered a call to the scientific bodies to have more studies, establish guidelines for management, and to have better awareness of this serious public health concern.

Keywords: androgenic anabolic steroid; andrology; reproductive health; urology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Showing the percentages of different medications used for treating androgenic‐anabolic steroid abuse‐related sexual dysfunction
Figure 2
Figure 2
Showing the percentages of different medications used for treating androgenic‐anabolic steroid abuse‐related infertility
See this image and copyright information in PMC

References

    1. Pope HG Jr., Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance‐enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341‐375. - PMC - PubMed
    1. Handelsman DJ. Commentary: androgens and "anabolic steroids": the one‐headed janus. Endocrinology. 2011;152(5):1752‐1754. - PubMed
    1. Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38(4):644‐651. - PubMed
    1. Alshammari S, AlShowair M, AlRuhaim A. Use of hormones and nutritional supplements among gyms' attendees in Riyadh. J Fam Community Med. 2017;24(1):6‐12. - PMC - PubMed
    1. Casavant MJ, Blake K, Griffith J, Yates A, Copley LM. Consequences of use of anabolic androgenic steroids. Pediatr Clin North Am. 2007;54(4):677‐690. - PubMed

LinkOut - more resources